79
Views
4
CrossRef citations to date
0
Altmetric
Case Report

INVASIVE ASPERGILLOSIS OF THE SMALL BOWEL IN AN INFANT WITH ACUTE MYELOID LEUKEMIA AND INTESTINAL OBSTRUCTION

, MB, ChB, MRCPCH, , MA, BM, BCh, DPhil, FRCPath, , MB, ChB, FRCPath, , MB, ChB, FRCS, FRCS(Paeds) & , MB, ChB, PhD, FRCPCH
Pages 84-91 | Received 08 Oct 2008, Accepted 30 Oct 2008, Published online: 09 Jul 2009

REFERENCES

  • Gibson BE, Wheatley K, Hann IM, et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005; 12: 2130–2138
  • Riley LC, Hann IM, Wheatley K, Stevens RF. Treatment related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council Acute Myeloid Leukaemia trial (MRC AML 10). Br J Haematol 1999; 106: 436–444
  • Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7–14
  • Woods WG, Kobrinsky N, Buckley JD, et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group. Blood 1996; 87: 4979–4989
  • Vormoor J, Ritter J, Creutzig U, et al. Acute myelogenous leukaemia in children under 2 years: Experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group. Br J Cancer 1992; 66: S63–S67
  • Hiçsönmez G, Çetin M, Tuncer AM, et al. Children with acute myeloblastic leukemia presenting with extramedullary infiltration: The effects of high-dose steroid treatment. Leuk Res 2004; 28: 25–34
  • Kobayashi R, Tawa A, Hanada R, Horibe K, Tsuchida M, Tsukimoto I. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia. Pediatr Blood & Cancer 2007; 48: 393–398
  • Paydas S, Zorludemir S, Ergin M. Granulocytic sarcoma: 32 cases and review of the literature. Leukemia & Lymphoma 2006; 47: 2527–2541
  • Dabbagh V, Browne G, Parapia LA, Price JJ, Batman PA. Granuloctic sarcoma of the rectum: A rare complication of myelodysplaia. J Clin Pathol 1999; 52: 865–866
  • Tummala M, Thomas L, Gocke C, Heyman MR, Gojo I. Unusual leukemia presentations, case 2: Granulocytic sarcoma of the colon. J Clin Oncol. 2005; 23: 5840–5841
  • Kohl SK, Aoun P. Granulocytoic sarcoma of the small intestine. Arch Pathol Lab Med 2006; 130: 1570–1574
  • Von Lilienfeld-Toal M, Ebert O, Theuerkauf I, Glasmacher A, Schmidt-Wolf IGH. Small bowel obstruction in acute myelogenous leukemia: Stenosis or paralysis?. Ann Hematol 2001; 80: 611–613
  • Pui MH, Fletcher BD, Lanston JW. Granulocytic sarcoma in childhood: Imaging features. Radiology 1994; 190: 698–702
  • Hunter BT, Bjelland JC. Gastrointestinal complications of leukaemia and its treatment. Am J Roentgenol. 1984; 142: 513–518
  • Shah SS, Birnbaum BA, Jacobs JE. Disseminated aspergillosis inciting intestinal ischaemia and obstruction. Br J Radiol 2001; 74: 1145–1147
  • Marterre WF, Jr, Mong AT, Pulito AR. Locally invasive aspergillosis of the bowel. J Pediatr Surg 1992; 27: 1611–1613
  • Rankin NE. Disseminated aspergillosis and moniliasis associated with agrnulocytosis and antibiotic therapy. BMJ 1953; 25: 918–919
  • Denning DW, Marinus A, Cohen J, , the EORTC Invasive Fungal Infections Cooperative Group, et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcomes. J Infect 1998; 37: 173–180
  • Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections: A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol. 2003; 119: 854–858
  • Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: A 10-year review. Pediatr Radiol 2003; 33: 453–460
  • Sambatakou H, Guiver M, Denning D. Pulmonary aspergillosis in a patient with chronic granulomatous disease: Confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole. Eur J Clin Microbiol Infect Dis 2003; 22: 681–685
  • Yeo SF, Wong B. Current status of non-culture methods for the diagnosis of invasive fungal infections. Clin Microbiol Rev. 2002; 15: 465–484
  • Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol. 2002; 20: 1898–1906
  • Viscoli C, Machetti M, Cappellano P, et al. False-positive galactomannan platelia. Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis. 2004; 38: 913–916
  • Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administrationof piperacillin and tazobactam. N Engl J Med 2003; 349: 2366–2367
  • Boutboul F, Alberti C, Leblanc T, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: Increasing antigenaemia is associated with progressive disease. Clin Infect Dis 2002; 34: 939–943
  • Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XY. Diagnosis of invasive mold infection by a quantitative real-time PCR. Am J Clin Pathol 2003; 119: 38–44
  • Senn L, Robinson JO, Schmidt S, et al. 1,3-b-d-Glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis. 2008; 46: 878–885
  • Prentice HG, Kibbler CC, Prentice AG. Towards a targeted, risk-based, antifungal strategy in neutropenic patients. Br J Haematol 2000; 110: 273–228
  • Bow EJ. Invasive fungal infections in patients receiving intensive cytotoxic therapy for cancer. Br J Haematol. 1998; 101(Suppl 1)1–4
  • Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006; 117: 711–716
  • Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment realted, ortality in children undergoing therapy for acute myeloid leukaemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004; 22: 4384–4393
  • Slats AM, Egeler RM, Van Der Does-van den Berg A, et al. Causes of death—Other than progressive leukemia—In childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): The Dutch Childhood Oncology Group experience. Leukemia 2005; 19: 537–544
  • Burgos A, Zaoutis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: A multicenter retrospective analysis of 139 contemporary cases. Pediatrics. 2008; 121: 1286–1294
  • Crassard N, Hadden H, Piens M, et al. Invasive aspergillosis in a paediatric haematology department: A 15-year review. Mycoses 2008; 51: 109–116
  • Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: A 34-year experience. Clin Infect Dis 1999; 29: 1210–1219
  • Mohite U, Kell J, O'Brien C, Kundu S, Rees J, Burnett AK. Invasive aspergillosis localised to the colon presenting as toxic megacolon. Eur J Haematol 2007; 78: 270–273

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.